Calibrate and Found are two of the most established direct-to-consumer medical weight loss platforms in the US, both offering GLP-1 medication access alongside behavioral and nutritional support. The two platforms have meaningfully different positioning — Calibrate is structured as a 12-month program with intensive weekly coaching, while Found offers a more flexible monthly subscription with broader medication options and lighter coaching. This calibrate vs found comparison breaks down 2026 pricing, the program structures, medication formularies, and which platform fits which patients better. The summary: Calibrate for patients who want structured intensive coaching with GLP-1 medication; Found for patients who want flexibility with broader medication options and lighter coaching support.
Calibrate vs Found — pricing in 2026
Calibrate pricing:
- Total Care 12-month program: $1,649 (billed upfront or in installments)
- Includes: clinician evaluation, monthly clinician visits, weekly coaching sessions, app-based curriculum, biometric tracking
- Medication separate: insurance-covered or out-of-pocket varying by drug
- Maintenance plan after 12 months: monthly subscription
- Results Guarantee: partial refund if patients don’t lose 10% of starting weight by month 12
Found pricing:
- Standard monthly subscription: $99-129/month (with annual prepay reducing per-month cost)
- Includes: clinician evaluation, monthly check-ins, asynchronous messaging with prescriber, app-based behavioral content
- Medication separate: varies by drug from generic ($10-30/month for metformin, bupropion) to branded GLP-1 ($1,000+/month without insurance)
- Optional one-on-one coaching at higher tiers
For program fees alone, Found at $99-129/month over 12 months ($1,188-1,548) is similar in total cost to Calibrate’s $1,649. The difference is structural — Calibrate’s upfront 12-month commitment vs Found’s flexible monthly subscription. See our individual Calibrate review and Found review.
Coaching intensity — Calibrate’s clearer differentiator
Calibrate’s coaching is structured weekly 30-45 minute sessions with a designated coach, covering goal-setting, troubleshooting, and behavior change across the 12-month program. The cumulative coaching contact across 12 months is substantial — roughly 30-40 hours of one-on-one coaching depending on engagement level.
Found’s coaching is lighter. The standard plan includes app-based behavioral content covering nutrition, exercise, sleep, and emotional health, with optional weekly check-ins through messaging. Higher-tier plans add one-on-one coaching, but the default experience is closer to “structured medication management with educational content” than Calibrate’s “intensive coaching with medication.”
For patients who want and will use intensive coaching, Calibrate’s model fits better. For patients with strong self-direction who don’t want or need structured coaching, Found’s lighter approach is genuinely a feature rather than a weakness.
Medication formulary — Found’s clearer advantage
Calibrate primarily prescribes FDA-approved GLP-1 weight loss medications: Wegovy, Zepbound, and (when legally available) compounded versions of semaglutide and tirzepatide. The formulary is narrow and GLP-1-focused.
Found’s formulary is broader:
- GLP-1 medications including Wegovy and Zepbound
- Metformin off-label for weight loss in patients with insulin resistance
- Bupropion (Wellbutrin) off-label, particularly when comorbid with depression
- Naltrexone, often combined with bupropion (Contrave)
- Topiramate off-label, often combined with phentermine (Qsymia)
- Other older weight loss medications based on patient profile
This formulary breadth matters because not every patient is a GLP-1 candidate, not every patient can afford GLP-1s, and not every patient responds best to GLP-1s. A patient with insulin resistance may do well on metformin at $10-15/month rather than spending $1,000+/month on Wegovy. A patient with comorbid depression may benefit from bupropion. Found’s medication-agnostic approach fits a wider range of patient profiles than Calibrate’s GLP-1-focused approach.
Clinical assessment depth
Found’s clinical assessment is more comprehensive than Calibrate’s. The Found intake covers metabolic markers, hormonal factors, behavioral history, prior weight loss attempts, and contraindications in greater depth, with the assessment data informing medication selection.
Calibrate’s clinical assessment is competent but less detailed, partly because the medication formulary is narrower and the assessment is structured around GLP-1 eligibility rather than broader matching across multiple medication options. For patients with complex metabolic profiles, Found’s assessment produces more refined treatment matching.
Outcomes and Results Guarantee
Calibrate publishes more outcome data than Found and includes a Results Guarantee — partial refund if patients meeting engagement requirements don’t lose at least 10% of starting weight by month 12. Calibrate’s published average outcomes show 13-15% weight loss at 12 months for program completers, comparable to GLP-1 clinical trial data.
Found doesn’t publish equivalent outcome data publicly and doesn’t offer a Results Guarantee. The platform’s outcome track record is reasonable but less transparently documented than Calibrate’s. For patients who value outcome guarantees and published data, Calibrate’s transparency is a real advantage.
Insurance integration and total cost
Both platforms have similar insurance integration patterns. Neither bills insurance for the program fee — both are out-of-pocket for the platform service. Both coordinate medication prescriptions with patient pharmacies where insurance can apply.
For patients with insurance covering GLP-1 medications well, both platforms produce similar total costs. For patients without GLP-1 coverage, Found’s broader formulary with cheaper medication options (metformin, bupropion, etc.) can substantially reduce total cost compared to Calibrate’s GLP-1-focused approach.
Specific use cases — when each platform wins
Choose Calibrate if: You want intensive structured coaching with weekly sessions. You’ll commit to a 12-month program. You’re a strong GLP-1 candidate (BMI 30+ or 27+ with comorbidities). You value the Results Guarantee and published outcome data. Insurance covers GLP-1 medications well.
Choose Found if: You want flexibility with monthly subscription rather than upfront commitment. You’re not necessarily a GLP-1 candidate or want broader medication options. You have insulin resistance, mild obesity, or budget constraints where cheaper non-GLP-1 medications might fit better. You prefer lighter coaching with stronger clinical assessment.
How both compare to Hims, Ro, and Noom Med
Compared to Hims and Ro weight loss programs, both Calibrate and Found offer more clinical depth and structured support. Hims and Ro deliver primarily medication access with minimal coaching; Calibrate and Found wrap the medication in either intensive coaching (Calibrate) or thorough clinical assessment with broader formulary (Found).
Compared to Noom Med, both Calibrate and Found have stronger clinical infrastructure while Noom Med leverages Noom’s broader behavioral curriculum. See our Noom vs Calibrate, Found vs Noom, and Ro vs Hims weight loss for further comparisons.
Frequently Asked Questions
Which is cheaper, Calibrate or Found?
Found is more flexible (monthly vs 12-month) at $99-129/month. Calibrate’s $1,649 12-month commitment is similar in total cost over a year. Found’s broader medication options can reduce total cost when patients don’t need GLP-1s specifically.
Does either platform take insurance?
Neither bills insurance for the program fee. Both coordinate medication prescriptions where insurance can apply to GLP-1s and other medications.
Which has better coaching?
Calibrate’s coaching is more intensive and structured. Found’s coaching is lighter and more app-based. The “better” choice depends on whether you want and will use intensive coaching.
Which prescribes Wegovy and Zepbound?
Both prescribe FDA-approved GLP-1 weight loss medications including Wegovy and Zepbound when clinically appropriate. Found also prescribes a broader range of older weight loss medications.
Can I commit to less than 12 months at Calibrate?
The standard Calibrate program is structured as a 12-month commitment. Found’s monthly subscription is more flexible if shorter-term commitment is needed.
The bottom line on Calibrate vs Found
Calibrate and Found serve overlapping but distinct patient profiles. Calibrate is the right choice for patients who want intensive structured coaching across a 12-month program with GLP-1 medications and value the Results Guarantee. Found is the right choice for patients who want flexibility, broader medication options beyond GLP-1s, and stronger clinical assessment with lighter coaching. Both are credible medical weight loss platforms with stronger clinical infrastructure than Hims, Ro, or Noom Med. The right choice depends primarily on whether intensive coaching or medication-formulary breadth matters more for your specific situation.